Fundraising FoxPegBio
Hangzhou, CN · 1 known investors
Find your way into PegBio
Sign up to see every warm intro you have to PegBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PegBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.
Investors · 1
In the news
Frequently asked questions
- What does PegBio do?
- PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.
- Who are PegBio's investors?
- PegBio's investors include YuanBio Venture Capital.
- Where is PegBio headquartered?
- PegBio is headquartered in Hangzhou, CN.